Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
CSW Industrials CEO Joseph Armes Sells 1,500 Shares
What Happened
Joseph B. Armes, Chairman, President & CEO (and Director) of CSW Industrials, sold 1,500 shares of CSW common stock in an open‑market sale on June 15, 2026. The weighted average sale price was $279.52 per share, for aggregate proceeds of $419,277. The sales were executed under a prearranged 10b5‑1 trading plan.
Key Details
- Transaction date: June 15, 2026 (reported on Form 4 filed June 16, 2026).
- Price: weighted average $279.52; individual sale prices ranged from $278.14 to $280.115 (report discloses the range).
- Shares sold: 1,500; proceeds ≈ $419,277.
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes of note:
- 10b5‑1 plan established August 12, 2025 (prearranged trading plan) — F1.
- Weighted average price and range disclosure, reporting person will provide per‑share breakdown on request — F2.
- Filing also discloses outstanding performance rights and restricted stock units with multi‑year TSR‑based vesting schedules (may be settled in cash or stock) — F3–F7.
- Timeliness: Filing appears timely (Form 4 filed the next day).
Context
- A sale executed pursuant to a 10b5‑1 plan is typically a prearranged transaction and does not necessarily indicate a change in the insider’s view of the company.
- The filing also lists various performance rights and restricted stock units that vest based on relative total shareholder return vs. the Russell 2000 over defined multi‑year performance cycles; these are contingent awards, not immediate share issuances.
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-06-15$279.52/sh−1,500$419,277→ 69,100 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 9,836
Performance Rights
[F3]→ Common Stock (9,836 underlying) - 8,004
Performance Rights
[F4]→ Common Stock (8,004 underlying) - 8,236
Performance Rights
[F5]→ Common Stock (8,236 underlying) - 9,186
Performance Rights
[F6]→ Common Stock (9,186 underlying) - 19,685
Restricted Stock Units
[F7]→ Common Stock (19,685 underlying)
Footnotes (7)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $278.14 to $280.115, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F7]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Signature
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes|2026-06-16